Drug Delivery Technology: SurModics, Inc. (SRDX)

• Publication date: April 2012
• Report size: 33 pages

SurModics, Inc. (SurModics) is a healthcare industry player engaged in providing surface modification and drug delivery technologies. These technologies are employed in the development of new medical devices, biomedical products and in the improvement of existing products and devices in the healthcare market . It operates in two business sectors , namely, Therapeutic and Diagnostic. SurModics’s core technology offerings include drug de...

SurModics, Inc. (SurModics) is a healthcare industry player engaged in providing surface modification and drug delivery technologies. These technologies are employed in the development of new medical devices, biomedical products and in the improvement of existing products and devices in the healthcare market . It operates in two business sectors , namely, Therapeutic and Diagnostic. SurModics’s core technology offerings include drug delivery technologies, surface modification coating technologies and components for in vitro diagnostic test kits. The industry player commercializes its technologies through licensing and royalty arrangements with medical device manufacturers. It operates through two subsidiaries, namely, BioFX Laboratories, Inc. and SurModics Pharmaceuticals, Inc. The industry player is headquartered in Minnesota, the US.

This report is a source for data, analysis and actionable intelligence on the SurModics, Inc. portfolio of new product development . The report provides detailed analysis on each pipeline product with data on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover data on product description, function, technology, indication, and application. The report is also supplemented with a detailed industry player profile and data on clinical trials, wherever applicable.
<2>
Scope of the Research

- Detailed industry player profile with data on business description, key industry player facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the new product development , by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional data on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with data on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, industry ing and sales strategies.
- Exploit Merger and Acquisition opportunities by identifying industry players with the most innovative pipeline.
- Develop successful market-entry strategies .
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ new product development through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

Drug Delivery Technology Industry

Data table of Contents
Data table of Contents 2
List of Tables 3
List of Figures 3
SurModics, Inc. - Business Overview 4
Key Facts 4
SurModics, Inc. - Major Products and Services 5
SurModics, Inc. Pipeline Products by Equipment Type 6
SurModics, Inc. Pipeline Products by Development Stage 7
SurModics, Inc. Pipeline Products by Therapy Area 8
Clinuvel Implant 9
Product Status 9
Product Description 9
I-vation Sustained Drug Delivery System-TA 9
Product Status 9
Product Description 9
Product Milestone 10
Neuraxo Implant 10
Product Status 10
Product Description 10
Renal Stent System 11
Product Status 11
Product Description 11
SurModics, Inc. - Top Competitors 12
SurModics, Inc. - Key Executives 13
SurModics, Inc. - Key Employee Biographies 14
SurModics, Inc. - Operations and Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
April 27, 2011: SurModics Reports Total Sales Of US$ 17.5m In Q2 Fiscal Year Ended 2011 16
January 26, 2011: SurModics Reports Total Sales s Of US$ 15.17 Mln In Q1 Fiscal 2011 16
January 05, 2011: SurModics Appoints David Dantzker And Jeffrey Smith To Board Of Directors 16
December 14, 2010: SurModics Appoints Gary Maharaj As New President, CEO 16
December 14, 2010: SurModics Appoints Gary Maharaj As New President And CEO 17
November 10, 2010: SurModics Reports Total Sales s Of US$ 69.9 Mln For Fiscal 2010 17
November 03, 2010: SurModics And Edge Therapeutics Collaborate On Development Of Sustained-Release Neurological Product 17
October 14, 2010: SurModics Announces Organizational Changes To Reduce Cost Structure And Renew Focus On Business Units 18
September 21, 2010: SurModics Appoints Scott Ward To Board 18
July 28, 2010: SurModics Reports Total Sales s Of US$ 18.60 Mln In Q3 Fiscal 2010 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20


List of Tables

SurModics, Inc., Major development 1
SurModics, Inc. Key Pipeline Products by Equipment Type 1
SurModics, Inc. Key Pipeline Products by Therapy Area 1
SurModics, Inc. Key Pipeline Products by Development Stage 1
SurModics, Inc. Key Pipeline Products by Trial Phase 1
SurModics, Inc., Major development 4
SurModics, Inc., Major Products and Services 5
SurModics, Inc. Number of Pipeline Products by Equipment Type 6
SurModics, Inc. Pipeline Products by Equipment Type 6
SurModics, Inc. Number of Pipeline Products by Development Stage 7
SurModics, Inc. Pipeline Products by Development Stage 7
SurModics, Inc. Number of Pipeline Products by Therapy Area 8
SurModics, Inc. Pipeline Products by Therapy Area 8
Clinuvel Implant - Product Status 9
Clinuvel Implant - Product Description 9
I-vation Sustained Drug Delivery System-TA - Product Status 9
I-vation Sustained Drug Delivery System-TA - Product Description 9
I-vation Sustained Drug Delivery System-TA - Product Milestone 10
Neuraxo Implant - Product Status 10
Neuraxo Implant - Product Description 10
Renal Stent System - Product Status 11
Renal Stent System - Product Description 11
SurModics, Inc., Key Executives 13
SurModics, Inc., Key Employee Biographies 14
SurModics, Inc., Subsidiaries 15


List of Figures

SurModics, Inc. Pipeline Products by Equipment Type 6
SurModics, Inc. Pipeline Products by Development Stage 7
SurModics, Inc. Pipeline Products by Therapy Area 8

Companies Mentioned
Abbott Laboratories
Medtronic, Inc.
Boston Scientific Corporation
W. L. Gore & Associates, Inc.
pSivida Corp.
Specialty Coating Systems, Inc.
QLT Inc.
Hydromer, Inc.
DURECT Corporation
DSM Biomedical Materials B.V.
Biosensors International Group, Ltd.
Biocompatibles International plc
AST Products, Inc.
Alkermes, Inc.